Skip to content
Stock screener

PCSA

Conviction 28HealthcareScan · Fri, Oct 9, 2026
Bullish engulfing

Processa Pharmaceuticals, Inc. (PCSA) closed at $1.52 (+12.59%) on Oct 9, 2026. Its latest daily candle is a bullish engulfing. Price is below its 50-day and below its 200-day moving average. RSI(14) 35, RS Rating 99, -77.9% from its 52-week high, -49.7% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

PCSA$1.52+12.59%
ResistanceSupportVol 14Insider buy
63 bars
Vol MA14 233.09K
Jul 14Jul 30Aug 18Sep 3Sep 23Oct 9
Processa Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.processapharmaceuticals.com ↗
Price1.52
Change+12.59%
Gap-4.44%
Rel volume410.90×
Avg volume466.27K
Avg $ vol692.89K
SMA 201.73
SMA 502.01
SMA 2002.48
Price vs 50-26.55%
Price vs 200-40.42%
MA stackbearish
50/200 cross—
Supertrenddown · 1.78
RSI (14)35
MACD hist-0.03
MACD cross—
Stoch %K / %D39 / 15
ADX (14)19
+DI / −DI25 / 21
RSI divergenceBullish
MACD divergenceBullish
ATR %12.37%
ADR %9.66%
52w high6.68
52w low0.1202
From 52w high-77.92%
Above 52w low+1127.12%
New 52w highNo
SqueezeOff
Bollinger width43.65%
%B0.16
Donchian pos35.20%
Donchian high2.11
Donchian low1.13
AVWAP (52w high)4.39
vs AVWAP high-66.38%
AVWAP (52w low)3.96
vs AVWAP low-62.77%
OBV trendUp
Chaikin MF (20)-0.06
Today vs 20d410.90×
Avg vol (14d)658.66K
Avg vol (20d)466.27K
Avg $ vol (20d)692.89K
Market cap4.12M
RS Rating99 / 99
RS 3m (vs SPY)-32.31%
RS 6m (vs SPY)-61.33%
RS line new highNo
Trend template2/8
Technical rank8.4
1 week-8.39%
1 month-20.27%
3 months-28.40%
6 months-46.75%
1 year+208.00%
YTD-49.66%
P/E-0.30
P/B-12.98
P/S—
P/FCF-0.36
EPS-10.36
Div yield1.04%
ROE—
ROA—
Debt/Eq-0.81
Current0.87
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-14.46%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value4.18M
Revenue0
Net income-3.27M
Gross profit5K
Free cash flow-11.39M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out—
Employees12
ListedMon, Oct 7, 2013
Free float1.91M
Float %84.4%
Short interest35.95K
Days to cover1.0d
Short volume56.9%
Squeeze score35 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction28 / 100
Pattern quality—
Tech rank8.4 / 100
Group rank14 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish engulfing

Financials as of Tue, Jun 30, 2026 · quarterly.

Recent news

Congress activity

Disclosed STOCK Act trades in PCSA

All disclosures →
No recent disclosed trades by Congress in PCSA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PCSA

InsiderSideShares
Ng George K
Chief Executive Officer · Common Stock · 2026-08-08
Exercise1.6K
Ng George K
Chief Executive Officer · Restricted Stock · 2026-08-08
Exercise1.6K
Guy Wendy
Chief Administrative Officer · Restricted Stock Units · 2026-07-26
Grant9.45K
Lin Patrick
Chief Business - Strategy Off · Restricted Stock Units · 2026-07-26
Grant8.45K
Neal James R
Director · Restricted Stock Units · 2026-07-26
Grant62.22K
Ng George K
Chief Executive Officer · Restricted Stock Units · 2026-07-26
Grant9.38K
Pannu Geraldine
Director · Restricted Stock Units · 2026-07-26
Grant33.5K
SKIBSTED RUSSELL
Chief Financial Officer · Restricted Stock Units · 2026-07-26
Grant11.88K
Yorke Justin W
Director · Restricted Stock Units · 2026-07-26
Grant33.5K
Baluch Khoso
Director · Restricted Stock Units · 2026-07-26
Grant33.5K

SEC filings

EDGAR filings in PCSA · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.